Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229) - Oh_2017_Diabetes.Obes.Metab_19_294 |
| Author(s) : Oh J , Kim AH , Lee S , Cho H , Kim YS , Bahng MY , Yoon SH , Cho JY , Jang IJ , Yu KS |
| Ref : Diabetes Obes Metab , 19 :294 , 2017 |
| Abstract : Oh_2017_Diabetes.Obes.Metab_19_294 |
| ESTHER : Oh_2017_Diabetes.Obes.Metab_19_294 |
| PubMedSearch : Oh_2017_Diabetes.Obes.Metab_19_294 |
| PubMedID: 27761990 |
| Title : Pharmacokinetic comparison using two tablets of an evogliptin\/metformin XR 2.5\/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg - Yoon_2017_Int.J.Clin.Pharmacol.Ther_55_533 |
| Author(s) : Yoon S , Rhee SJ , Park SI , Yoon SH , Cho JY , Jang IJ , Lee S , Yu KS |
| Ref : Int J Clinical Pharmacology & Therapeutics , 55 :533 , 2017 |
| Abstract : Yoon_2017_Int.J.Clin.Pharmacol.Ther_55_533 |
| ESTHER : Yoon_2017_Int.J.Clin.Pharmacol.Ther_55_533 |
| PubMedSearch : Yoon_2017_Int.J.Clin.Pharmacol.Ther_55_533 |
| PubMedID: 28406090 |
| Title : The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans - Oh_2017_PLoS.One_12_e0176320 |
| Author(s) : Oh J , Lee S , Lee H , Cho JY , Yoon SH , Jang IJ , Yu KS , Lim KS |
| Ref : PLoS ONE , 12 :e0176320 , 2017 |
| Abstract : Oh_2017_PLoS.One_12_e0176320 |
| ESTHER : Oh_2017_PLoS.One_12_e0176320 |
| PubMedSearch : Oh_2017_PLoS.One_12_e0176320 |
| PubMedID: 28437488 |
| Title : Pharmacokinetics of the evogliptin\/metformin extended-release (5\/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects - Rhee_2016_Drug.Des.Devel.Ther_10_1411 |
| Author(s) : Rhee SJ , Lee S , Yoon SH , Cho JY , Jang IJ , Yu KS |
| Ref : Drug Des Devel Ther , 10 :1411 , 2016 |
| Abstract : Rhee_2016_Drug.Des.Devel.Ther_10_1411 |
| ESTHER : Rhee_2016_Drug.Des.Devel.Ther_10_1411 |
| PubMedSearch : Rhee_2016_Drug.Des.Devel.Ther_10_1411 |
| PubMedID: 27110098 |
| Title : Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers - Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| Author(s) : Gu N , Park MK , Kim TE , Bahng MY , Lim KS , Cho SH , Yoon SH , Cho JY , Jang IJ , Yu KS |
| Ref : Drug Des Devel Ther , 8 :1709 , 2014 |
| Abstract : Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| ESTHER : Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| PubMedSearch : Gu_2014_Drug.Des.Devel.Ther_8_1709 |
| PubMedID: 25336915 |
| Title : Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers - Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| Author(s) : Lim KS , Cho JY , Kim BH , Kim JR , Kim HS , Kim DK , Kim SH , Yim HJ , Lee SH , Shin SG , Jang IJ , Yu KS |
| Ref : British Journal of Clinical Pharmacology , 68 :883 , 2009 |
| Abstract : Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| ESTHER : Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| PubMedSearch : Lim_2009_Br.J.Clin.Pharmacol_68_883 |
| PubMedID: 20002082 |
| Title : Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study - Lim_2008_Clin.Ther_30_1817 |
| Author(s) : Lim KS , Kim JR , Choi YJ , Shin KH , Kim KP , Hong JH , Cho JY , Shin HS , Yu KS , Shin SG , Kwon OH , Hwang DM , Kim JA , Jang IJ |
| Ref : Clin Ther , 30 :1817 , 2008 |
| Abstract : Lim_2008_Clin.Ther_30_1817 |
| ESTHER : Lim_2008_Clin.Ther_30_1817 |
| PubMedSearch : Lim_2008_Clin.Ther_30_1817 |
| PubMedID: 19014837 |